Literature DB >> 10645303

Serotonin syndrome with fluoxetine plus tramadol.

S Kesavan1, G M Sobala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10645303      PMCID： PMC1297365          DOI： 10.1177/014107689909200915

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

Review 1.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

2.  Serotonin syndrome following the administration of tramadol with paroxetine.

Authors:  M S Lantz; E N Buchalter; V Giambanco
Journal:  Int J Geriatr Psychiatry       Date:  1998-05       Impact factor: 3.485

3.  Possible serotonin syndrome associated with tramadol and sertraline coadministration.

Authors:  B J Mason; K H Blackburn
Journal:  Ann Pharmacother       Date:  1997-02       Impact factor: 3.154

4.  Serotonin syndrome secondary to phenelzine-venlafaxine interaction.

Authors:  L A Weiner; M Smythe; J Cisek
Journal:  Pharmacotherapy       Date:  1998 Mar-Apr       Impact factor: 4.705

5.  Treatment of the serotonin syndrome with cyproheptadine.

Authors:  A Graudins; A Stearman; B Chan
Journal:  J Emerg Med       Date:  1998 Jul-Aug       Impact factor: 1.484
  5 in total
  11 in total

Review 1.  [Polypharmacy and pain treatment].

Authors:  Markus Gosch; Birgit Böhmdorfer; Ursula Benvenuti-Falger; Peter Dovjak; Bernhard Iglseder; Monika Lechleitner; Ronald Otto; Regina E Roller; Ulrike Sommeregger
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 2.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  [Analgesics in geriatric patients. Adverse side effects and interactions].

Authors:  Markus Gosch
Journal:  Z Gerontol Geriatr       Date:  2015-07       Impact factor: 1.281

Review 4.  Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors:  J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal:  Forensic Sci Med Pathol       Date:  2010-11-04       Impact factor: 2.007

Review 5.  [Depression in cancer patients].

Authors:  Barbara Sperner-Unterweger
Journal:  Wien Med Wochenschr       Date:  2015-07-04

6.  Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice.

Authors:  Meredith A Fox; Catherine L Jensen; Dennis L Murphy
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-11       Impact factor: 5.176

7.  Mutations in monoamine oxidase (MAO) genes in mice lead to hypersensitivity to serotonin-enhancing drugs: implications for drug side effects in humans.

Authors:  M A Fox; M G Panessiti; P R Moya; T J Tolliver; K Chen; J C Shih; D L Murphy
Journal:  Pharmacogenomics J       Date:  2012-09-11       Impact factor: 3.550

8.  Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2009-04

9.  Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?

Authors:  Petra E Spies; J L W Hans Pot; Roel P J Willems; Jacqueline M Bos; Cornelis Kramers
Journal:  Eur J Hosp Pharm       Date:  2016-03-23

10.  Serotonin syndrome in a postoperative patient.

Authors:  Minati Choudhury; Milind P Hote; Yashwant Verma
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.